BCR-mediated Uptake of Antigen Linked to TLR9 Ligand Stimulates B-cell Proliferation and Antigen-specific Plasma Cell Formation
Overview
Authors
Affiliations
The activation of Toll-like receptor 9 (TLR9) expressed within B cells is associated with enhanced humoral immunity. However the role of TLR9 in the stimulation of B-cell responses, and more specifically in shaping the outcome of B-cell differentiation, remains unclear. Here, we observed that immunization with the TLR9 agonist CpG linked to protein antigen gave rise to enhanced production of antigen-specific class-switched antibodies in vivo. Unlike dendritic cells, B cells are unable to acquire these conjugates by macropinocytosis and instead depend on uptake through a signaling-competent B-cell receptor (BCR), provided the overall BCR-antigen avidity exceeds a defined threshold. The resultant stimulation of intrinsic TLR9 leads to enhanced antigen-specific B-cell proliferation and differentiation to form extrafollicular plasma cells. Thus, the direct conjugation of antigen and CpG reveals a mechanism that may operate during the initiation of primary immune responses, and may prove useful as a strategy for the design of adjuvants suitable for vaccinations.
Opportunities and limitations of B cell depletion approaches in SLE.
Stockfelt M, Teng Y, Vital E Nat Rev Rheumatol. 2025; 21(2):111-126.
PMID: 39815102 DOI: 10.1038/s41584-024-01210-9.
Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment.
Shi X, Cheng X, Jiang A, Shi W, Zhu L, Mou W Adv Sci (Weinh). 2024; 11(47):e2403423.
PMID: 39509319 PMC: 11653663. DOI: 10.1002/advs.202403423.
An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens.
Wholey W, Meyer A, Yoda S, Mueller J, Mathenge R, Chackerian B J Immunol. 2024; 213(8):1061-1075.
PMID: 39212443 PMC: 11458362. DOI: 10.4049/jimmunol.2400101.
Cerrillos-Gutierrez J, Medina-Perez M, Andrade-Sierra J, Garcia-Sanchez A, Cardona-Munoz E, Campos-Perez W Int J Mol Sci. 2024; 25(13).
PMID: 39000140 PMC: 11241645. DOI: 10.3390/ijms25137023.
He Y, Vinuesa C Adv Immunol. 2024; 162:109-133.
PMID: 38866437 PMC: 7616122. DOI: 10.1016/bs.ai.2024.02.002.